Nail tattooing: a novel and minimally invasive technique for enhancing drug penetration through the nail

Research Projects

Organizational Units

Journal Issue

Abstract

Onychomycosis, a prevalent fungal infection, and psoriasis, a chronic immune disorder affecting the nail plate, present therapeutic challenges due to the limited efficacy of current treatments, often leading to prolonged therapy and a high relapse rate. The highly cross-linked keratin network of the nail plate acts as a barrier, impeding effective drug delivery. This pioneering study explores a novel approach using a tattoo device to enhance drug penetration through the nail. Ciclopirox olamine and clobetasol lacquers were selected as the model formulations. Drug permeation tests conducted on non-treated, filed (mechanically abraded), and tattooed nails demonstrated significantly higher drug permeation in tattooed nails, suggesting the potential of this delivery method. Nail tattooing offers a simple method to enhance topical therapy, allowing treatment initiation in the clinic and continuation at home.

Description

Bibliographic citation

Bendicho-Lavilla, C., Díaz-Tomé, V., Seoane-Viaño, I., Monte-Vidal, V. de, & Otero-Espinar, F.J. (2026) Nail tattooing: a novel and minimally invasive technique for enhancing drug penetration through the nail. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-026-02102-z

Relation

Has part

Has version

Is based on

Is part of

Is referenced by

Is version of

Requires

Sponsors

I.S.V. and V.D.T. acknowledge Consellería de Cultura, Educación e Universidade for their Postdoctoral Fellowships (Xunta de Galicia, Spain; ED481D-2024-011, and ED481B-2023-092, respectively). This project has been funded by Axencia Galega de Innovación (Grupo de Referencia Competitiva, ED431C 2025/08).
Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This project has been funded by Axencia Galega de Innovación (Grupo de Referencia Competitiva, ED431C 2025/08).

Rights

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons. org/licenses/by/4.0/.
Attribution 4.0 International